JDPRX
Price
$17.17
Change
-$0.10 (-0.58%)
Updated
Sep 20 closing price
JVMTX
Price
$30.35
Change
-$0.19 (-0.62%)
Updated
Sep 20 closing price
Ad is loading...

JDPRX vs JVMTX

Header iconJDPRX vs JVMTX Comparison
Open Charts JDPRX vs JVMTXBanner chart's image
Janus Henderson Mid Cap Value R
Price$17.17
Change-$0.10 (-0.58%)
VolumeN/A
CapitalizationN/A
JHancock Disciplined Value Mid Cap R4
Price$30.35
Change-$0.19 (-0.62%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JDPRX vs JVMTX Comparison Chart
Loading...
VS
JDPRX vs. JVMTX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDPRX is a StrongBuy and JVMTX is a Buy.

FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 23.4B vs. JDPRX (2.13B). JVMTX pays higher dividends than JDPRX: JVMTX (0.73) vs JDPRX (0.49). JDPRX was incepted earlier than JVMTX: JDPRX (15 years) vs JVMTX (11 years). JDPRX is a more actively managed with annual turnover of: 54.00 vs. JVMTX (41.00). JVMTX has a lower initial minimum investment than JDPRX: JVMTX (0) vs JDPRX (2500). JVMTX annual gain was more profitable for investors over the last year : 19.27 vs. JDPRX (16.95). JVMTX return over 5 years is better than : 43.64 vs. JDPRX (13.69).
JDPRXJVMTXJDPRX / JVMTX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years11 years-
Gain YTD14.90411.010135%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.13B23.4B9%
Annual Yield % from dividends0.490.7367%
Returns for 1 year16.9519.2788%
Returns for 3 years1.6913.3813%
Returns for 5 years13.6943.6431%
Returns for 10 years-25.0463.34-40%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALVR0.78-0.01
-0.85%
AlloVir
LEA108.02-2.00
-1.82%
Lear Corp
RWAY10.13-0.24
-2.31%
Runway Growth Finance Corp
SLNO51.50-1.23
-2.33%
Soleno Therapeutics
TIVC0.27-0.01
-3.57%
Tivic Health Systems